Wan Shan Chen
Fortune : 5 M $ au 30/06/2026
Fortune : 5 M $ au 30/06/2026
Ms. Wan Shan Chen is a Head-Finance & Accounting Department at Lin BioScience, Inc. She is on the Board of Directors at Belite Bio, Inc. Ms. Chen was previously employed as a Finance Manager by CVie Therapeutics Ltd. and an Assistant Manager-Audit Department by Deloitte & Touche.
She received her graduate degree from National Taipei University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BELITE BIO, INC. 0,13% | 09/04/2026 | 32 559 ( 0,13% ) | 5 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BELITE BIO, INC | Directeur/Membre du Conseil | 01/11/2021 |
| LIN BIOSCIENCE, INC. | Directeur Financier/CFO | 25/07/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Directeur Financier/CFO | 01/01/2016 |
Deloitte & Touche
Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Provides audit, enterprise risk management and financial advisory services | Corporate Officer/Principal | 01/01/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Deloitte & Touche
Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Provides audit, enterprise risk management and financial advisory services | Commercial Services |
National Taipei University
National Taipei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lin BioScience, Inc.
Lin BioScience, Inc. BiotechnologyHealth Technology Engages in discovering and development of drugs for cancer treatment and eye diseases | Health Technology |
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Health Technology |
Belite Bio, Inc.
Belite Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical drug development company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national